Biocompatibility Testing

In this soundbite from RCA Radio, Dr. Helin Raagel and Dr. Matthew Jorgensen from Nelson Labs explain biocompatibility testing. This includes the risk-based biocompatibility evaluation that medical devices go through before they receive regulatory approval.

This biocompatibility risk-based approach evaluates the risk of the device through consideration of the device’s cytotoxicity, irritation, and sensitization. 

• Cytotoxicity – Will the device kill or harm the cells it comes in contact with?
• Irritation – Will the device make contact with the patient and cause skin irritation? (Redness and/or Swelling)
• Sensitization – Will the device cause an allergic reaction?

Listen to the full episode “Intro to Pre-Clinical Testing and Biocompatibility” now!

To begin the Regulatory Compliance Associates scoping process today, please enter your information in the blue form below and click the submit button at the bottom of the webpage. You may also email us at [email protected].